|
English
|
正體中文
|
简体中文
|
2822924
|
|
???header.visitor??? :
30054182
???header.onlineuser??? :
985
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"ichikawa w"???jsp.browse.items-by-author.description???
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
國家衛生研究院 |
2017-08 |
A randomized phase II study of gemcitabine plus Z-360, a CCK2 receptor-selective antagonist, in patients with metastatic pancreatic cancer as compared with gemcitabine plus placebo
|
Ueno, M;Li, CP;Ikeda, M;Ishii, H;Mizuno, N;Yamaguchi, T;Ioka, T;Oh, DY;Ichikawa, W;Okusaka, T;Matsuyama, Y;Arai, D;Chen, LT;Park, YS;Furuse, J |
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
|